BRIDGEBIO ONCOLOGY THERAPEUT
BBOT·107924102·US·Common Stock·Healthcare - Biotechnology-Activist
BBOT (BRIDGEBIO ONCOLOGY THERAPEUT) is held by 40 institutional investors as of Q2 2026. Largest holders: Alphabet Inc. ($21.5M), WELLINGTON MANAGEMENT GROUP LLP ($21.3M), CITADEL ADVISORS LLC ($19.9M). Net institutional sentiment: Mixed.
40
Holders
(2 Elite)
$135.6M
Total Value
52% (42)
Consensus
22 buying - 20 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Oct 15, 2026 · Insiders Jul 6, 2026 · Activists Jul 6, 2026 · Congress none
ActivistBCBihua Chen22.3%Jul 6, 2026
InsiderBPBeltran PedroTax 1K shJul 1, 2026
InsiderBYBen YongTax 1K shJul 1, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 47
1 / 3
Continue exploring
Other Healthcare stocks held by institutions
417 holders · $300.5B
416 holders · $881.6B
401 holders · $151.5B
398 holders · $415.6B
395 holders · $98.9B
394 holders · $111.8B
391 holders · $230.3B
386 holders · $303.9B
386 holders · $52.4B
383 holders · $114.2B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer